{"schema_version":"alpha-profile-public-v1","slug":"nicholas-a-saccomano-ph-d","canonical_url":"https://registry.alpha.ac/people/nicholas-a-saccomano-ph-d","as_of":"2026-09-21T20:22:26.976686+00:00","published_at":"2026-09-02T02:37:24.503971+00:00","last_reviewed_at":"2026-05-16T06:23:50.252+00:00","identity":{"display_name":"Nicholas A. Saccomano, Ph.D.","headshot_url":null,"headshot_media":null,"profile_kind":"director","role_tags":["director","executive"],"current_role":{"company_name":"OnKure Therapeutics, Inc.","company_slug":"onkure-therapeutics-inc","exchange":"NASDAQ","ticker":"OKUR","role_category":"director","title":"Director","committee":null,"is_board_chair":false,"is_independent":false,"valid_from":"2024-01-01","valid_to":null,"is_current":true,"verification_status":"confirmed","confidence":0.85,"evidence":{"source_type":"sec_proxy","source_url":"https://www.sec.gov/Archives/edgar/data/1637715/000114036126015903/ny20066577x1_def14a.htm","effective_date":"2026-04-21","last_checked_at":"2026-04-24T23:35:02.481+00:00"}},"photo_match":null},"assurance":{"is_claimed":false,"status":"unverified","assurance_level":null,"method":null,"verified_at":null,"expires_at":null},"claiming":{"eligible":true,"label":"Is this you? Claim your Alpha Profile","claim_url":"https://terminal.alpha.ac/claim-profile?person=nicholas-a-saccomano-ph-d","suggest_edit_label":"Suggest an edit","suggest_edit_url":"https://terminal.alpha.ac/claim-profile?person=nicholas-a-saccomano-ph-d&mode=suggest","canonical_record_will_be_reused":true,"canonical_facts_owner_controlled":false},"presentation":{"schema_version":"alpha-profile-presentation-v1","state":"alpha_editorial","version":0,"published_at":null,"headline":null,"headline_evidence":null,"location":null,"photo":null,"cover":null,"about":["Over 30 years of experience in pharmaceutical and biotechnology research and development with expertise in discovery research, clinical development, portfolio strategy, and technology. Previously Chief Science Officer at Pfizer's Boulder facility and Chief Technology Officer at SomaLogic."],"links":[],"sources":[],"featured":[],"competencies":[],"board_preferences":null,"board_service":[{"organization":"OnKure Therapeutics, Inc.","organizationId":"onkure-therapeutics-inc","title":"Director","period":"2024-01-01 · current","evidenceLabel":"sec_proxy","evidenceState":"verified","sourceUrl":"https://www.sec.gov/Archives/edgar/data/1637715/000114036126015903/ny20066577x1_def14a.htm"}],"experience":[],"education":[],"credentials":[],"section_order":null,"hidden_sections":[],"limitations":["Presentation fields do not alter independently verified Alpha Profile facts.","Owner-supplied résumé records retain their field-level evidence state.","Only confirmed company_person_roles with public evidence. Website governed_site_fallback rows are not invented. about/links are stored people.profile_summary/bio and linkedin_url only. Dates stay undisclosed when the role has no start_date. SoFi Bank is not SoFi Technologies."]},"presentation_authority":"confirmed_company_person_roles","roles":[{"company_name":"OnKure Therapeutics, Inc.","company_slug":"onkure-therapeutics-inc","exchange":"NASDAQ","ticker":"OKUR","role_category":"director","title":"Director","committee":null,"is_board_chair":false,"is_independent":false,"valid_from":"2024-01-01","valid_to":null,"is_current":true,"verification_status":"confirmed","confidence":0.85,"evidence":{"source_type":"sec_proxy","source_url":"https://www.sec.gov/Archives/edgar/data/1637715/000114036126015903/ny20066577x1_def14a.htm","effective_date":"2026-04-21","last_checked_at":"2026-04-24T23:35:02.481+00:00"}}],"claims":[{"claim_type":"ai_ml_experience","claim_value":false,"claim_text":"Proxy extraction classified AI/ML experience for Nicholas A. Saccomano, Ph.D. as false.","claim_state":"verified","valid_from":null,"valid_to":null,"confidence":0.72,"source_tier":3,"verification_status":"confirmed","last_reviewed_at":"2026-05-16T01:36:51.889291+00:00","version":1,"evidence":[{"source_name":"SEC EDGAR","document_title":"OKUR DEF 14A director slate","source_type":"sec_filing","source_tier":3,"source_url":"https://www.sec.gov/Archives/edgar/data/1637715/000114036126015903/ny20066577x1_def14a.htm","published_at":"2026-04-21T00:00:00+00:00","last_checked_at":"2026-05-16T01:36:51.766043+00:00","relation":"supports","excerpt_locator":null}]},{"claim_type":"ai_ml_experience","claim_value":false,"claim_text":"Executive extraction classified AI/ML experience for Nicholas A. Saccomano, Ph.D. as false.","claim_state":"verified","valid_from":null,"valid_to":null,"confidence":0.72,"source_tier":3,"verification_status":"confirmed","last_reviewed_at":"2026-05-16T06:23:50.449634+00:00","version":1,"evidence":[{"source_name":"SEC EDGAR","document_title":"OKUR 10-K executive officers","source_type":"sec_filing","source_tier":3,"source_url":"https://www.sec.gov/Archives/edgar/data/1637715/000119312526104147/okur-20251231.htm","published_at":"2026-03-12T00:00:00+00:00","last_checked_at":"2026-05-16T06:23:50.308148+00:00","relation":"supports","excerpt_locator":null}]},{"claim_type":"board_role","claim_value":"Director","claim_text":"Nicholas A. Saccomano, Ph.D. currently serves as Director at OnKure Therapeutics, Inc..","claim_state":"verified","valid_from":"2026-04-21","valid_to":null,"confidence":0.92,"source_tier":3,"verification_status":"confirmed","last_reviewed_at":"2026-05-16T01:36:51.848551+00:00","version":1,"evidence":[{"source_name":"SEC EDGAR","document_title":"OKUR DEF 14A director slate","source_type":"sec_filing","source_tier":3,"source_url":"https://www.sec.gov/Archives/edgar/data/1637715/000114036126015903/ny20066577x1_def14a.htm","published_at":"2026-04-21T00:00:00+00:00","last_checked_at":"2026-05-16T01:36:51.766043+00:00","relation":"supports","excerpt_locator":null}]},{"claim_type":"committee_assignments","claim_value":[],"claim_text":"Nicholas A. Saccomano, Ph.D. serves on no disclosed committees.","claim_state":"verified","valid_from":"2026-04-21","valid_to":null,"confidence":0.88,"source_tier":3,"verification_status":"confirmed","last_reviewed_at":"2026-05-16T01:36:51.868687+00:00","version":1,"evidence":[{"source_name":"SEC EDGAR","document_title":"OKUR DEF 14A director slate","source_type":"sec_filing","source_tier":3,"source_url":"https://www.sec.gov/Archives/edgar/data/1637715/000114036126015903/ny20066577x1_def14a.htm","published_at":"2026-04-21T00:00:00+00:00","last_checked_at":"2026-05-16T01:36:51.766043+00:00","relation":"supports","excerpt_locator":null}]},{"claim_type":"current_executive_company","claim_value":"OnKure Therapeutics, Inc.","claim_text":"Nicholas A. Saccomano, Ph.D. is linked to OnKure Therapeutics, Inc. as an operating executive.","claim_state":"verified","valid_from":null,"valid_to":null,"confidence":0.85,"source_tier":3,"verification_status":"confirmed","last_reviewed_at":"2026-05-16T01:36:52.013472+00:00","version":1,"evidence":[{"source_name":"SEC EDGAR","document_title":"OKUR DEF 14A director slate","source_type":"sec_filing","source_tier":3,"source_url":"https://www.sec.gov/Archives/edgar/data/1637715/000114036126015903/ny20066577x1_def14a.htm","published_at":"2026-04-21T00:00:00+00:00","last_checked_at":"2026-05-16T01:36:51.766043+00:00","relation":"supports","excerpt_locator":null}]},{"claim_type":"current_executive_role","claim_value":"Chief Executive Officer and President","claim_text":"Nicholas A. Saccomano, Ph.D. is also listed as Chief Executive Officer and President.","claim_state":"verified","valid_from":null,"valid_to":null,"confidence":0.85,"source_tier":3,"verification_status":"confirmed","last_reviewed_at":"2026-05-16T01:36:51.991216+00:00","version":1,"evidence":[{"source_name":"SEC EDGAR","document_title":"OKUR DEF 14A director slate","source_type":"sec_filing","source_tier":3,"source_url":"https://www.sec.gov/Archives/edgar/data/1637715/000114036126015903/ny20066577x1_def14a.htm","published_at":"2026-04-21T00:00:00+00:00","last_checked_at":"2026-05-16T01:36:51.766043+00:00","relation":"supports","excerpt_locator":null}]},{"claim_type":"cybersecurity_experience","claim_value":false,"claim_text":"Proxy extraction classified cybersecurity experience for Nicholas A. Saccomano, Ph.D. as false.","claim_state":"verified","valid_from":null,"valid_to":null,"confidence":0.72,"source_tier":3,"verification_status":"confirmed","last_reviewed_at":"2026-05-16T01:36:51.929061+00:00","version":1,"evidence":[{"source_name":"SEC EDGAR","document_title":"OKUR DEF 14A director slate","source_type":"sec_filing","source_tier":3,"source_url":"https://www.sec.gov/Archives/edgar/data/1637715/000114036126015903/ny20066577x1_def14a.htm","published_at":"2026-04-21T00:00:00+00:00","last_checked_at":"2026-05-16T01:36:51.766043+00:00","relation":"supports","excerpt_locator":null}]},{"claim_type":"cybersecurity_experience","claim_value":false,"claim_text":"Executive extraction classified cybersecurity experience for Nicholas A. Saccomano, Ph.D. as false.","claim_state":"verified","valid_from":null,"valid_to":null,"confidence":0.72,"source_tier":3,"verification_status":"confirmed","last_reviewed_at":"2026-05-16T06:23:50.482247+00:00","version":1,"evidence":[{"source_name":"SEC EDGAR","document_title":"OKUR 10-K executive officers","source_type":"sec_filing","source_tier":3,"source_url":"https://www.sec.gov/Archives/edgar/data/1637715/000119312526104147/okur-20251231.htm","published_at":"2026-03-12T00:00:00+00:00","last_checked_at":"2026-05-16T06:23:50.308148+00:00","relation":"supports","excerpt_locator":null}]},{"claim_type":"executive_company","claim_value":"OnKure Therapeutics, Inc.","claim_text":"Nicholas A. Saccomano, Ph.D. is associated with OnKure Therapeutics, Inc..","claim_state":"verified","valid_from":"2026-03-12","valid_to":null,"confidence":0.94,"source_tier":3,"verification_status":"confirmed","last_reviewed_at":"2026-05-16T06:23:50.431866+00:00","version":1,"evidence":[{"source_name":"SEC EDGAR","document_title":"OKUR 10-K executive officers","source_type":"sec_filing","source_tier":3,"source_url":"https://www.sec.gov/Archives/edgar/data/1637715/000119312526104147/okur-20251231.htm","published_at":"2026-03-12T00:00:00+00:00","last_checked_at":"2026-05-16T06:23:50.308148+00:00","relation":"supports","excerpt_locator":null}]},{"claim_type":"executive_title","claim_value":"President and Chief Executive Officer","claim_text":"Nicholas A. Saccomano, Ph.D. is listed as President and Chief Executive Officer at OnKure Therapeutics, Inc..","claim_state":"verified","valid_from":"2026-03-12","valid_to":null,"confidence":0.94,"source_tier":3,"verification_status":"confirmed","last_reviewed_at":"2026-05-16T06:23:50.412483+00:00","version":1,"evidence":[{"source_name":"SEC EDGAR","document_title":"OKUR 10-K executive officers","source_type":"sec_filing","source_tier":3,"source_url":"https://www.sec.gov/Archives/edgar/data/1637715/000119312526104147/okur-20251231.htm","published_at":"2026-03-12T00:00:00+00:00","last_checked_at":"2026-05-16T06:23:50.308148+00:00","relation":"supports","excerpt_locator":null}]},{"claim_type":"other_company_role","claim_value":{"role":"Board Member","company":"BioLoomics, Inc., Gyges Therapeutics, Kestrel Therapeutics Inc., and Modulo Bio, Inc."},"claim_text":"Nicholas A. Saccomano, Ph.D. is also linked to BioLoomics, Inc., Gyges Therapeutics, Kestrel Therapeutics Inc., and Modulo Bio, Inc. as Board Member.","claim_state":"verified","valid_from":null,"valid_to":null,"confidence":0.7,"source_tier":3,"verification_status":"confirmed","last_reviewed_at":"2026-05-16T06:23:50.514746+00:00","version":1,"evidence":[{"source_name":"SEC EDGAR","document_title":"OKUR 10-K executive officers","source_type":"sec_filing","source_tier":3,"source_url":"https://www.sec.gov/Archives/edgar/data/1637715/000119312526104147/okur-20251231.htm","published_at":"2026-03-12T00:00:00+00:00","last_checked_at":"2026-05-16T06:23:50.308148+00:00","relation":"supports","excerpt_locator":null}]},{"claim_type":"technology_background","claim_value":false,"claim_text":"Proxy extraction classified technology background for Nicholas A. Saccomano, Ph.D. as false.","claim_state":"verified","valid_from":null,"valid_to":null,"confidence":0.72,"source_tier":3,"verification_status":"confirmed","last_reviewed_at":"2026-05-16T01:36:51.909692+00:00","version":1,"evidence":[{"source_name":"SEC EDGAR","document_title":"OKUR DEF 14A director slate","source_type":"sec_filing","source_tier":3,"source_url":"https://www.sec.gov/Archives/edgar/data/1637715/000114036126015903/ny20066577x1_def14a.htm","published_at":"2026-04-21T00:00:00+00:00","last_checked_at":"2026-05-16T01:36:51.766043+00:00","relation":"supports","excerpt_locator":null}]},{"claim_type":"technology_background","claim_value":true,"claim_text":"Executive extraction classified technology background for Nicholas A. Saccomano, Ph.D. as true.","claim_state":"verified","valid_from":null,"valid_to":null,"confidence":0.72,"source_tier":3,"verification_status":"confirmed","last_reviewed_at":"2026-05-16T06:23:50.465719+00:00","version":1,"evidence":[{"source_name":"SEC EDGAR","document_title":"OKUR 10-K executive officers","source_type":"sec_filing","source_tier":3,"source_url":"https://www.sec.gov/Archives/edgar/data/1637715/000119312526104147/okur-20251231.htm","published_at":"2026-03-12T00:00:00+00:00","last_checked_at":"2026-05-16T06:23:50.308148+00:00","relation":"supports","excerpt_locator":null}]},{"subject":"alpha:person:nicholas-a-saccomano-ph-d","claim_type":"board_service","claim_value":{"tags":[],"title":"Director","period":"2024-01-01 · current","organization":"OnKure Therapeutics, Inc.","organization_id":"onkure-therapeutics-inc"},"claim_text":"Director at OnKure Therapeutics, Inc. (2024-01-01 · current)","valid_from":null,"valid_to":null,"verification_status":"confirmed","date_precision":"period_text_only","evidence":[{"source_url":"https://www.sec.gov/Archives/edgar/data/1637715/000114036126015903/ny20066577x1_def14a.htm","label":"sec_proxy","evidence_state":"verified"}],"claim_state":"confirmed","version":1}],"network":{"schema_version":"alpha-profile-network-public-v1","relationships":[],"relationship_pathfinding":false,"authentication_prompt":"Sign in to see how you're connected.","limitations":["Representative factual associations only.","Shared contexts do not assert personal acquaintance.","Anonymous graph traversal is not available."]},"permissions":{"classification":"open_public_projection","public_retrieval":true,"agent_retrieval":true,"redistribution":false,"model_training":false,"relationship_pathfinding":false,"direct_contact":false},"limitations":["Only permissioned public claims and evidence are included.","Absence of a claim is not evidence that the underlying fact is false.","Public retrieval does not grant model-training or redistribution rights.","Private relationships and Council activity are excluded."],"structured_data":{"@context":"https://schema.org","@type":"ProfilePage","@id":"https://registry.alpha.ac/people/nicholas-a-saccomano-ph-d#profile","url":"https://registry.alpha.ac/people/nicholas-a-saccomano-ph-d","dateModified":"2026-05-16T06:23:50.252+00:00","mainEntity":{"@type":"Person","@id":"https://registry.alpha.ac/people/nicholas-a-saccomano-ph-d#person","name":"Nicholas A. Saccomano, Ph.D.","url":"https://registry.alpha.ac/people/nicholas-a-saccomano-ph-d","jobTitle":"Director","worksFor":{"@type":"Organization","name":"OnKure Therapeutics, Inc.","tickerSymbol":"NASDAQ: OKUR"},"affiliation":[{"@type":"OrganizationRole","roleName":"Director","startDate":"2024-01-01","memberOf":{"@type":"Organization","name":"OnKure Therapeutics, Inc.","url":"https://registry.alpha.ac/companies/onkure-therapeutics-inc","tickerSymbol":"NASDAQ: OKUR"}}]},"isBasedOn":[{"@type":"CreativeWork","url":"https://www.sec.gov/Archives/edgar/data/1637715/000114036126015903/ny20066577x1_def14a.htm","name":"OKUR DEF 14A director slate"},{"@type":"CreativeWork","url":"https://www.sec.gov/Archives/edgar/data/1637715/000119312526104147/okur-20251231.htm","name":"OKUR 10-K executive officers"}],"mainEntityOfPage":"https://registry.alpha.ac/people/nicholas-a-saccomano-ph-d"},"trust":{"schema_version":"alpha-profile-trust-v1","verification":{"schema_version":"alpha-verification-states-v1","state":"corroborated","identity_ownership":"unclaimed","assurance_level":null,"claim_state_counts":{"source_reported":9,"corroborated":3,"alpha_verified":0,"disputed":0,"superseded":0},"derivation":"claim_states+identity_ownership","summary":"At least one published claim is corroborated by two or more public sources. Profile ownership is unclaimed."},"aggregation":{"schema_version":"alpha-claim-aggregation-v1","published_claim_count":12,"under_review_claim_count":0,"owner_supplied_claim_count":0,"evidence_record_count":4,"distinct_source_count":2,"conflicts":[{"claim_type":"technology_background","kind":"extraction_disagreement","headline":false,"review_route":"internal_review","values":["false","true"],"publishers":["SEC EDGAR"],"source_types":["sec_filing"],"rationale":"Pipeline extraction runs disagree over documents from one publisher; routed to internal review, not headlined."}],"conflict_count":1,"headline_conflict_count":0,"internal_review_conflict_count":1,"contradiction_types":["technology_background"],"headline_conflict_types":[],"verification":{"schema_version":"alpha-verification-states-v1","state":"corroborated","identity_ownership":"unclaimed","assurance_level":null,"claim_state_counts":{"source_reported":9,"corroborated":3,"alpha_verified":0,"disputed":0,"superseded":0},"derivation":"claim_states+identity_ownership","summary":"At least one published claim is corroborated by two or more public sources. Profile ownership is unclaimed."},"coverage":{"schema_version":"alpha-coverage-metric-v1","published_claims":12,"corroborated_claims":3,"sources":4,"distinct_sources":2,"role_claims":1,"last_reviewed_at":"2026-05-16T06:23:50.252+00:00","observed_at":"2026-09-21T20:22:26.976686+00:00","freshness_days":129}},"rights":{"public_retrieval":"allowed","agent_retrieval":"allowed","redistribution":"not_granted","model_training":"not_granted","commercial_use":"not_specified","relationship_pathfinding":"not_granted","direct_contact":"not_granted"}},"projection":{"schema_version":"alpha-profile-projection-v5","entity":{"kind":"person","slug":"nicholas-a-saccomano-ph-d","canonical_url":"https://registry.alpha.ac/people/nicholas-a-saccomano-ph-d"},"publication":{"published_at":"2026-09-02T02:37:24.503971+00:00","last_reviewed_at":"2026-05-16T06:23:50.252+00:00","as_of":"2026-09-21T20:22:26.976686+00:00"},"representations":{"html":{"href":"https://registry.alpha.ac/people/nicholas-a-saccomano-ph-d","media_type":"text/html"},"json":{"href":"https://registry.alpha.ac/api/public/profiles/nicholas-a-saccomano-ph-d","media_type":"application/json"},"markdown":{"href":"https://registry.alpha.ac/people/nicholas-a-saccomano-ph-d.md","media_type":"text/markdown"},"structured_data":{"embedded":true,"media_type":"application/ld+json"},"share_image":null},"permissions":{"public_retrieval":true,"agent_retrieval":true,"redistribution":false,"model_training":false,"relationship_pathfinding":false,"direct_contact":false}}}